• 100+

    The UK’s most active investor in UK university spin-outs

  • £300M

    Over £300m raised; invested into over 100 companies

  • 17 wins

    Award winning manager with track record of delivering returns

  • £1.2Bn

    Part of FTSE 250 sector specialist group with £1.2bn net assets

About Parkwalk

Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.

Covid-19 Update: We continue to operate as usual, supporting the best of our technology companies. We accept applications by email and are having video updates with investors and advisers. Further details here.

Performance

We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.

Learn More

Meet the Parkwalk team

Combining our diverse range of skills and experience with integrity and transparency the Parkwalk team has an outstanding track record for supporting high-growth innovation that delivers returns.

Moray Wright
Olivia Goodchild
Alastair Kilgour
Meet the team

Empowering Innovation

Parkwalk Funds invest in dynamic university spin-out companies seeking to commercialise intellectual property and technology. From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses.

Dynamic Vision Systems

Dynamic Vision Systems builds electronics on curved surfaces. The company brings leading expertise in liquid crystals, novel manufacturing and ophthalmology / optometry together to create smart contact lenses.

Predictimmune

Predictimmune is a molecular diagnostics company developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases. At diagnosis there is no way of knowing whether a patient is likely to experience a severe, relapsing form of the disease or a more quiescent and easier to manage pathway. The ability to stratify patients at the

RoadMap Systems

ROADMap is a pioneering technology company in the field of optical telecommunication and data communication switching. The Company is developing unique and novel technology in wavelength selective switches (WSSs). These switches are currently used to create reconfigurable optical add/drop multiplexers (ROADMs) which are now a fast growing part of the optical network where they enable

View Portfolio